Clinical Trial: A Study of Bomedemstat (MK-3543) in Participants With Mild or Moderate Hepatic Impairment (MK-3543-023)
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Hepatic Insufficiency
Study Type: INTERVENTIONAL
Official Title: An Open-Label, Single-Dose Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of MK-3543
Brief Summary:
The purpose of this study is to learn what happens to bomedemstat (MK-3543) in a person's body over time.Researchers will compare what happens to bomedemstat in the body when it is given to participants with mild or moderate hepatic (liver) impairment and healthy participants.Participants will be allocated to one of three groups: mild hepatic impairment (HI), moderate HI, or healthy matched control.All participants will receive a single oral dose of bomedemstat on Day 1.Healthy control participants will be…
Read more